Aug 4, 2026 04:26PM
Aug 4, 2026 04:11PM
Jul 27, 2026 06:47AM
Jul 23, 2026 07:10AM
Jul 13, 2026 04:07PM
Jul 2, 2026 06:43AM
Jun 22, 2026 12:36PM EU approves Arrowhead's plozasiran for rare triglyceride disorder
Jun 16, 2026 04:07PM
May 27, 2026 07:00AM
May 26, 2026 10:00AM
May 7, 2026 04:04PM
May 5, 2026 08:03AM
May 1, 2026 07:30AM
May 1, 2026 01:56AM JPMorgan Starts Arrowhead Pharma (ARWR) at Overweight
Apr 21, 2026 03:34AM
Mar 30, 2026 04:21AM
Mar 26, 2026 02:33PM
Mar 26, 2026 11:12AM
Mar 25, 2026 03:05PM
Mar 18, 2026 09:21AM
Feb 9, 2026 09:46AM Goldman Sachs Reiterates Neutral Rating on Arrowhead Pharma (ARWR)
Feb 5, 2026 04:11PM
Feb 4, 2026 05:18PM
Jan 27, 2026 09:58AM
Jan 22, 2026 06:40AM
Jan 16, 2026 07:07AM
Jan 13, 2026 09:07AM
Jan 12, 2026 05:05PM Arrowhead Pharmaceuticals raises $700 million in convertible notes
Jan 7, 2026 08:36AM
Jan 7, 2026 07:45AM
Jan 7, 2026 07:32AM
Jan 7, 2026 04:16AM
Jan 7, 2026 03:58AM
Jan 6, 2026 07:30AM
Jan 5, 2026 07:30AM Health Canada approves Arrowhead's REDEMPLO for rare triglyceride disorder
Jan 2, 2026 08:22AM
Dec 23, 2025 05:30PM
Dec 22, 2025 07:06AM
Dec 21, 2025 04:00AM
Dec 19, 2025 09:06AM
Dec 17, 2025 06:56AM
Dec 11, 2025 06:06AM Arrowhead Pharmaceuticals Inc. (ARWR) files mixed shelf
Dec 11, 2025 05:59AM
Dec 3, 2025 06:42AM
Dec 1, 2025 06:26AM
Nov 24, 2025 07:30AM
Nov 19, 2025 09:14AM
Nov 19, 2025 09:06AM
Nov 19, 2025 08:51AM Arrowhead Pharma (ARWR) PT Raised at Piper Sandler Following FDA Approval
Nov 19, 2025 07:28AM

433,570 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All